Anti-Inflammatory Activity of an In Vitro Digested Anthocyanin-Rich Extract on Intestinal Epithelial Cells Exposed to TNF-α

Molecules. 2022 Aug 23;27(17):5368. doi: 10.3390/molecules27175368.

Abstract

Background: The consumption of foods rich in anthocyanins (ACN) have been associated with beneficial properties in chronic inflammatory disorders such as intestinal bowel diseases (IBD). These effects were attributed not only to a direct antioxidant mechanism but also to the modulation of cell redox-dependent signaling. However, ACN bioavailability is low for their poor stability in the digestive tract, so ACN gastrointestinal digestion should be considered.

Methods: To have a more realistic knowledge of the effects of ACN, we performed an in vitro simulated gastrointestinal digestion of an ACN-rich purified and standardized bilberry and blackcurrant extract (BBE), followed by an evaluation of ACN composition modification (HPLC-DAD and pH differential method) and antioxidant activity (FRAP assay). Then, we studied the effects of BBE gastrointestinal extract on Caco-2 exposed to TNF-α.

Results: The results confirmed the high instability of ACN in the mild alkaline environment of the small intestine (17% recovery index). However, the digested BBE maintained part of its bioactivity. Additionally, BBE gastrointestinal extract inhibited the TNF-α-induced NF-κB pathway in Caco-2 and activated the Nrf2 pathway.

Conclusions: Although ACN stability is affected by gastrointestinal digestion, the anti-inflammatory and antioxidant activity of digested extracts were confirmed; thus, the loss of ACN can probably be counterweighed by their metabolites. Then, ACN introduced by diet or food supplements could represent an approach for IBD prevention.

Keywords: NF-κB; adaptative cellular response; anthocyanins; biostability; in vitro digestion; inflammation; inflammatory bowel disease.

MeSH terms

  • Anthocyanins / metabolism
  • Anthocyanins / pharmacology
  • Anti-Inflammatory Agents / metabolism
  • Anti-Inflammatory Agents / pharmacology
  • Antioxidants / metabolism
  • Antioxidants / pharmacology
  • Caco-2 Cells
  • Epithelial Cells
  • Humans
  • Inflammatory Bowel Diseases* / drug therapy
  • Inflammatory Bowel Diseases* / metabolism
  • Plant Extracts / chemistry
  • Ribes* / metabolism
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Anthocyanins
  • Anti-Inflammatory Agents
  • Antioxidants
  • Plant Extracts
  • Tumor Necrosis Factor-alpha

Grants and funding

This research received no external funding.